Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[An immunological approach to acute myeloid leukaemia].

Anales de pediatria (Barcelona, Spain : 2003) - 1 Apr 2016

González B, Bueno D, Rubio P M, San Román S, Plaza D, Sastre A, García-Miguel P, Fernández L, Valentín J, Martínez I, Pérez-Martínez A

Abstract excerpt

INTRODUCTION: Acute myeloid leukaemia (AML) is the second haematological malignancy in the paediatric population, and one of the leading causes of childhood cancer mortality. Survival is currently around 60%, with no improvement in last decades, suggesting that new therapeutic approaches are needed. The anti-leukaemia effect mediated by the lymphocytes and natural killer (NK) cells of the immune system has been...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carrier Proteins
Share to Child

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, MHC Class I

Share to Histocompatibility Antigens Class I

Share to Killer Cells, Natural

Share to Leukemia, Myeloid, Acute

Share to Membrane Proteins

Share to Phenotype

Source

Identifiers

PMID: 26776165
DOI: 10.1016/j.anpedi.2015.07.004

Genes

MICA
ULBP1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[An immunological approach to acute myeloid leukaemia].PMID 26776165Read ↗

High-Risk Leukemia: Past, Present, and Future Role of NK CellsSemantic proximity Read ↗

Adoptive NK cell therapy in AML: progress and challengesSemantic proximity Read ↗

Improving the Outcome of Leukemia by Natural Killer Cell-Based Immunotherapeutic StrategiesSemantic proximity Read ↗

Human NK receptors: From the molecules to the therapy of high risk leukemiasSemantic proximity Read ↗

Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association StudySemantic proximity Read ↗

The role of exhausted natural killer cells in the immunopathogenesis and treatment of leukemia.Semantic proximity Read ↗

Immunological classification of acute myeloblastic leukemias: relevance to patient outcomeSemantic proximity Read ↗

Association of killer cell immunoglobulin-like receptors and their cognate HLA class I ligands with susceptibility to acute myeloid leukemia in Iranian patients.Semantic proximity Read ↗

Phenotype of NK Cells Determined on the Basis of Selected Immunological Parameters in Children Treated due to Acute Lymphoblastic Leukemia.Semantic proximity Read ↗

Natural killer cells and acute myeloid leukaemiaSemantic proximity Read ↗

HLA-B*44 and the Bw4-80T motif are associated with poor outcome of relapse-preventive immunotherapy in acute myeloid leukemiaSemantic proximity Read ↗

Natural killer receptor ligand expression on acute myeloid leukemia impacts survival and relapse after chemotherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.